Lataa...
Affordable orphan drugs: a role for not‐for‐profit organizations
AIMS: The success of the Regulation on Orphan Medicinal Products in the European Union is evidenced by the 127 orphan drugs that have had market authorization since 2000. However, the incentives aimed at stimulating research and development have had the unintended consequence of increasing drug cost...
Tallennettuna:
| Julkaisussa: | Br J Clin Pharmacol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5465340/ https://ncbi.nlm.nih.gov/pubmed/28109021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13240 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|